Zelthy-Digital PSP Platform
What is this product? Zelthy Digital PSP Platform is a modular application for running patient support programs in pharma and life sciences. It provides a unified operational layer for managing the full patient lifecycle — from initial identification and enrollment through ongoing therapy support, adherence monitoring, and outcomes reporting. The platform supports multi-therapy, multi-market deployments and integrates AI agents for enrollment validation, adherence prediction, and adverse event detection across all program stages. Key Features & Functionalities - End-to-end patient enrollment with document verification and eligibility checks - Adherence monitoring using refill data, PROs, and pharmacy claims - Call center management with scheduling, queue routing, and post-call documentation - AI-powered adverse event detection during patient interactions - Outcomes tracking and real-time program analytics dashboards - Multi-channel patient communication (SMS, email, WhatsApp, app) - Configurable per therapy area and regulatory jurisdiction Primary Solution & Value The platform addresses a core operational challenge in pharma patient services: fragmented workflows across enrollment, adherence, and reporting that result in low patient participation and poor program visibility. By consolidating the full PSP workflow on a single platform with embedded AI agents, it enables pharmaceutical companies to increase enrollment rates, detect adherence risks earlier, and generate auditable outcomes data — without managing multiple point solutions or vendor integrations.
Who Is the Company Behind Zelthy-Digital PSP Platform?
- Seller: Zelthy
- Year Founded: 2017
- HQ Location: Seattle, US
-
LinkedIn® Page: www.linkedin.com
33 employees on LinkedIn®

